Free Trial

Danske Bank A S Makes New Investment in Amrize Ltd $AMRZ

Amrize logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Danske Bank opened a new position in Amrize (NYSE:AMRZ), acquiring 101,900 shares in Q4 worth about $5.51 million, while other institutions — notably Vanguard, Wellington and Marshall Wace — also substantially increased their stakes.
  • Analysts are broadly positive with a consensus rating of "Moderate Buy" and an average price target of $64.21, amid mixed target changes from brokers such as JPMorgan (raised) and Citi/Wells Fargo/RBC (trimmed).
  • Insiders bought 77,834 shares (~$4.51 million) last quarter and the company declared a $0.11 per‑share dividend payable May 20, even as Amrize slightly missed quarterly EPS expectations while reporting 4.7% revenue growth year‑over‑year.
  • MarketBeat previews top five stocks to own in June.

Danske Bank A S acquired a new position in Amrize Ltd (NYSE:AMRZ - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 101,900 shares of the company's stock, valued at approximately $5,511,000.

Several other hedge funds have also added to or reduced their stakes in AMRZ. Vanguard Group Inc. raised its position in Amrize by 41.0% in the third quarter. Vanguard Group Inc. now owns 30,094,083 shares of the company's stock worth $1,468,460,000 after acquiring an additional 8,743,543 shares during the period. Wellington Management Group LLP raised its position in Amrize by 48.8% in the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock worth $561,018,000 after acquiring an additional 3,809,133 shares during the period. Marshall Wace LLP raised its position in Amrize by 865.4% in the third quarter. Marshall Wace LLP now owns 2,889,660 shares of the company's stock worth $139,436,000 after acquiring an additional 2,590,336 shares during the period. Amundi bought a new stake in Amrize in the third quarter worth about $104,047,000. Finally, Vaughan Nelson Investment Management L.P. bought a new stake in Amrize in the third quarter worth about $92,166,000.

Analyst Ratings Changes

Several brokerages have commented on AMRZ. Wall Street Zen raised shares of Amrize from a "sell" rating to a "hold" rating in a research report on Sunday, March 1st. JPMorgan Chase & Co. lifted their target price on shares of Amrize from $60.00 to $70.00 and gave the stock an "overweight" rating in a research note on Thursday, March 5th. Citigroup reduced their target price on shares of Amrize from $76.00 to $66.00 and set a "buy" rating for the company in a research note on Monday. Wells Fargo & Company reduced their target price on shares of Amrize from $66.00 to $65.00 and set an "overweight" rating for the company in a research note on Wednesday, April 15th. Finally, Royal Bank Of Canada reduced their target price on shares of Amrize from $61.00 to $60.00 and set a "sector perform" rating for the company in a research note on Friday. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $64.21.

Check Out Our Latest Analysis on AMRZ

Insider Activity at Amrize

In other news, insider Mario Gross acquired 3,200 shares of Amrize stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average price of $55.29 per share, with a total value of $176,928.00. Following the completion of the purchase, the insider owned 30,947 shares in the company, valued at approximately $1,711,059.63. The trade was a 11.53% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Jaime Hill acquired 3,184 shares of Amrize stock in a transaction that occurred on Monday, March 9th. The shares were purchased at an average cost of $56.34 per share, with a total value of $179,386.56. Following the purchase, the insider owned 26,000 shares of the company's stock, valued at $1,464,840. This represents a 13.96% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 77,834 shares of company stock valued at $4,511,344 in the last quarter. 0.54% of the stock is currently owned by company insiders.

Amrize Price Performance

AMRZ opened at $50.94 on Tuesday. The firm has a 50-day moving average price of $57.86 and a 200-day moving average price of $54.96. The company has a market capitalization of $28.18 billion and a price-to-earnings ratio of 24.38. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $65.94. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37.

Amrize (NYSE:AMRZ - Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The firm had revenue of $2.18 billion for the quarter. Amrize had a net margin of 9.70% and a return on equity of 9.88%. Amrize's revenue was up 4.7% on a year-over-year basis. Equities analysts expect that Amrize Ltd will post 2.72 EPS for the current year.

Amrize Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, May 12th.

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines